S Ugurel Selected Research

S Ugurel Research Topics

Disease

33	Melanoma (Melanoma, Malignant) 11/2020 - 09/2000
17	Neoplasms (Cancer) 01/2022 - 01/2001
9	Neoplasm Metastasis (Metastasis) 12/2021 - 01/2001
3	Disease Progression 11/2021 - 08/2000
3	Circulating Neoplastic Cells 03/2001 - 01/2001
2	Hemangiosarcoma (Angiosarcoma) 09/2021 - 02/2009
2	Body Weight (Weight, Body) 01/2001 - 08/2000
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Skin Neoplasms (Skin Cancer) 12/2021
1	Eccrine Porocarcinoma 12/2021
1	Merkel Cell Carcinoma 11/2021
1	Fatigue 11/2021
1	Uveal melanoma 11/2020
1	Erythema Nodosum 09/2015
1	Hemorrhage 07/2011
1	Renal Cell Carcinoma (Grawitz Tumor) 07/2011
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2008
1	Brain Neoplasms (Brain Tumor) 10/2006
1	Panniculitis 09/2003
1	Cutaneous Malignant Melanoma 07/2003
1	Hematemesis 06/2003
1	Dyspepsia (Indigestion) 06/2003
1	Hypersensitivity (Allergy) 04/2003
1	Lymphatic Metastasis 01/2001

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 12/2021 - 09/2001
5	ImmunosorbentsIBA 01/2020 - 01/2001
5	EnzymesIBA 01/2020 - 01/2001
4	Imatinib Mesylate (Gleevec)FDA Link 10/2008 - 04/2003
4	Messenger RNA (mRNA)IBA 09/2001 - 01/2001
4	Interferon-alpha (Interferon Alfa)IBA 07/2001 - 01/2000
3	Immune Checkpoint InhibitorsIBA 01/2022 - 11/2020
3	Phosphotransferases (Kinase)IBA 12/2021 - 07/2014
3	InterferonsIBA 07/2011 - 07/2001
3	Temozolomide (Temodar)FDA LinkGeneric 04/2008 - 09/2000
3	Dacarbazine (DIC)FDA LinkGeneric 04/2006 - 04/2001
3	Monophenol Monooxygenase (Tyrosinase)IBA 03/2001 - 01/2001
2	B7-H1 AntigenIBA 11/2020 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 02/2005
2	VemurafenibIBA 09/2015 - 03/2015
2	Cisplatin (Platino)FDA LinkGeneric 09/2015 - 09/2000
2	Sorafenib (BAY 43-9006)FDA Link 07/2011 - 10/2008
2	Imiquimod (Aldara)FDA LinkGeneric 08/2006 - 09/2002
2	Interleukin-2 (IL2)IBA 02/2004 - 04/2001
2	HLA-G Antigens (HLA G)IBA 04/2002 - 07/2001
2	Cytostatic AgentsIBA 07/2001 - 01/2001
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2001 - 01/2001
2	Complementary DNA (cDNA)IBA 01/2001 - 01/2001
2	Methylprednisolone FDA LinkGeneric 01/2001 - 08/2000
1	Cyclin-Dependent Kinase Inhibitor p16IBA 12/2021
1	erucylphosphocholineIBA 12/2021
1	Delta CateninIBA 12/2021
1	2-methylphenyl cinnamateIBA 12/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	trametinibIBA 09/2015
1	Small Interfering RNA (siRNA)IBA 09/2015
1	dabrafenibIBA 09/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2009
1	Etanercept (Enbrel)FDA Link 10/2008
1	Adalimumab (Humira)FDA Link 10/2008
1	Infliximab (Remicade)FDA Link 10/2008
1	Sunitinib (Sutent)FDA Link 10/2008
1	Alefacept (Amevive)FDA Link 10/2008
1	efalizumab (Raptiva)FDA Link 10/2008
1	peginterferon alfa-2b (Pegintron)FDA Link 04/2008
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 10/2006
1	Hyaluronan ReceptorsIBA 05/2006
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2006
1	Conditioned Culture MediaIBA 05/2006
1	Peptides (Polypeptides)IBA 04/2006
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 04/2005
1	Tumor Biomarkers (Tumor Markers)IBA 02/2005
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 02/2005
1	liposomal doxorubicin (Doxil)FDA Link 12/2004
1	AntigensIBA 07/2003
1	Retinaldehyde (Retinal)IBA 07/2003
1	EpitopesIBA 07/2003
1	RNA (Ribonucleic Acid)IBA 09/2001
1	Ribonucleases (Ribonuclease)IBA 09/2001
1	Histocompatibility Antigens Class IIBA 07/2001
1	HLA Antigens (Human Leukocyte Antigens)IBA 07/2001
1	LigandsIBA 05/2001
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2001
1	Interleukin-8 (Interleukin 8)IBA 01/2001
1	angiogeninIBA 01/2001
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2001
1	Granzymes (Granzyme)IBA 01/2001
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2001
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2001
1	Interleukin-15 (Interleukin 15)IBA 01/2001

Therapy/Procedure

25	Therapeutics 12/2021 - 08/2000
7	Drug Therapy (Chemotherapy) 09/2021 - 06/2003
5	Immunotherapy 01/2022 - 07/2001
1	Withholding Treatment 11/2021
1	Duration of Therapy 11/2021
1	Molecular Targeted Therapy 10/2008
1	Oral Administration 10/2006
1	Lymph Node Excision (Lymph Node Dissection) 06/2003
1	Tonsillectomy 06/2003